SCHEMBL593144

SCHEMBL593144

Fc1ccccc1CN1CCNCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.68
CYP2A13 Q16696 1/20 0.64
LMNA P02545 2/20 0.62
SIGMAR1 Q99720 1/20 0.56
POLB P06746 3/20 0.55
KDM4E B2RXH2 5/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
KMT2A Q03164 4/20 0.54
ATM Q13315 2/20 0.54
HTT P42858 1/20 0.51
HTR1A P08908 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
MEN1 O00255 2/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7438574 1.00 ALDH1A1 (0.68) ALDH1A1CYP2A13LMNASIGMAR1POLB
Hydrochloric Acid SCHEMBL3033058 0.98 ALDH1A1 (0.66) ALDH1A1CYP2A13LMNASIGMAR1POLB
Hydrochloric Acid SCHEMBL7426057 0.98 ALDH1A1 (0.66) ALDH1A1CYP2A13LMNASIGMAR1POLB
SCHEMBL7098276 0.86 LMNA (0.55) ALDH1A1CYP2A13LMNASIGMAR1POLB
SCHEMBL16226380 0.86 ALDH1A1 (0.81) ALDH1A1CYP2A13LMNAPOLBKDM4E
SCHEMBL2925434 0.86 LMNA (0.54) ALDH1A1CYP2A13LMNASIGMAR1POLB
SCHEMBL3262128 0.82 ALDH1A1 (0.96) ALDH1A1CYP2A13LMNAPOLBKDM4E
SCHEMBL5752361 0.82 SIGMAR1 (0.51) ALDH1A1LMNASIGMAR1POLBKDM4E
Hydrochloric Acid SCHEMBL23850789 0.81 ALDH1A1 (0.85) ALDH1A1CYP2A13LMNAPOLBKDM4E
SCHEMBL807350 0.81 ALDH1A1 (1.00) ALDH1A1CYP2A13LMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116496272-B 7-Benzyl piperazinyl-9-allyl dehydropeganine derivative and preparation method and application thereof 延安大学 2024-08-13 CN claimed
CN-116496272-A 7-benzyl piperazinyl-9-allyl dehydropeganine derivative and preparation method and application thereof 延安大学 2023-07-28 CN claimed
CN-104046246-B The chemical-mechanical planarization of tungsten-containing substrate 气体产品与化学公司 2016-06-15 CN claimed
US-20140273458-A1 Chemical Mechanical Planarization for Tungsten-Containing Substrates AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-18 US claimed
EP-2779217-A2 Chemical mechanical planarization for tungsten-containing substrates AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-17 EP claimed
CN-104046246-A Chemical Mechanical Planarization for Tungsten-Containing Substrates AIR PROD & CHEM 2014-09-17 CN claimed
EP-2006271-A9 SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2009-07-29 EP claimed
US-20090054401-A1 Substituted bicyclic derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2009-02-26 US claimed
EP-2006271-A2 SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2008-12-24 EP claimed
CN-119859122-B Tyrosinase inhibitor and preparation method and application thereof 杭州师范大学 2025-06-13 CN disclosed
CN-119859122-A Tyrosinase inhibitor and preparation method and application thereof 杭州师范大学 2025-04-22 CN disclosed
CN-116496272-B 7-Benzyl piperazinyl-9-allyl dehydropeganine derivative and preparation method and application thereof 延安大学 2024-08-13 CN disclosed
CN-114380825-B Substituted pyrazole condensed ring derivative and preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2024-02-13 CN disclosed
US-20230312542-A1 HYDROXYPYRROLIDINE DERIVATIVE AND MEDICINAL APPLICATION THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-10-05 US disclosed
WO-1996015792-A9 METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE USING SUBSTITUTED 1-ARYL-3-PIPERAZIN-1'-YL PROPANONES 1996-09-12 WO disclosed
WO-1996016052-A2 CERTAIN SUBSTITUTED 1-ARYL-3-PIPERAZIN-1'-YL PROPANONES MOLECULAR GERIATRICS CORPORATION (US) 1996-05-30 WO disclosed
WO-1996015792-A1 METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE USING SUBSTITUTED 1-ARYL-3-PIPERAZIN-1'-YL PROPANONES MOLECULAR GERIATRICS CORPORATION (US) 1996-05-30 WO disclosed
US-5219857-A Method of treating cognitive and related neural behavioral problems AMERICAN CYANAMID COMPANY (US) 1993-06-15 US disclosed
US-5126340-A Antidepressants AMERICAN CYANAMID COMPANY (US) 1992-06-30 US disclosed
US-4963553-A TREATING COGNITIVE AND NEURAL BEHAVIORAL PROBLEMS IN MAMMALS AMERICAN CYANAMID CO. (US) 1990-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054401-A1 Substituted bicyclic derivatives and use thereof LTB4R2, LTC4S, LTB4R ALDH1A1 1731/4885CYP2A13 274/4885LMNA 1739/4885
US-20230312542-A1 HYDROXYPYRROLIDINE DERIVATIVE AND MEDICINAL APPLICATION THEREOF VHL, MDM2, NEDD4 ALDH1A1 2395/4885CYP2A13 3946/4885LMNA 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.